{"id":"W2528885621","doi":"10.1016/j.jtho.2016.08.075","title":"P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Nintedanib; Medicine; Pemetrexed; Internal medicine; Bevacizumab; Oncology; Vascular endothelial growth factor; Docetaxel; Chemotherapy; Cisplatin; Idiopathic pulmonary fibrosis; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001425308,0.001151464,0.001715186,0.0003539187,0.0004316769,0.001218597,0.0008880122,0.0008268944,0.005325927],"category_scores_gemma":[0.0006603251,0.000632866,0.001451185,0.0003112262,0.001050867,0.0009844633,0.000461476,0.003183202,0.001197052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009059811,"about_ca_system_score_gemma":0.00151761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001441609,"about_ca_topic_score_gemma":0.004597524,"domain_scores_codex":[0.9995835,0.0001934333,0.00001987002,0.00007332704,0.00003181373,0.00009795973],"domain_scores_gemma":[0.9996048,0.00005108598,0.00004850636,0.00003185904,0.00002071917,0.0002430681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8209423,0.0344226,0.01105028,0.0009014505,0.00192736,0.0001507256,0.0002289746,0.002230568,0.03432634,0.000265061,0.004706934,0.08884746],"study_design_scores_gemma":[0.6338678,0.338047,0.01983272,0.00004284352,0.0009707484,0.0001525296,0.0000732198,0.001062112,0.002752339,0.0001483475,0.003018181,0.00003218449],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920642,0.002333831,0.0003174144,0.0008066396,0.0002018854,0.001072756,0.001126767,0.00010369,0.001972775],"genre_scores_gemma":[0.9887664,0.001832905,0.001129898,0.0009020527,0.000192604,0.001282474,0.002184395,0.00004020493,0.003669036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005325927,"threshold_uncertainty_score":0.01781696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01639916723428391,"score_gpt":0.3704216414859611,"score_spread":0.3540224742516772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}